Sign in to confirm you’re not a bot
This helps protect our community. Learn more
Can Targeted Therapies Move the Field Toward More Individualized Bladder Cancer Treatment?
0Likes
52Views
2023Jul 6
A roundtable discussion, moderated by Vadim Koshkin, MD, of the University of California, San Francisco, focused on treatment selection for different patient populations with advanced bladder cancer, including a discussion of new data presented at ASCO 2023. Dr. Koshkin was joined by a panel that included Matthew Zibelman, MD; Cora Sternberg, MD; and Daniel Petrylak, MD. In the next segment of the roundtable series, the panel discusses the potential for more targeted treatments making their way into the advanced bladder cancer space.

Follow along using the transcript.

GU Oncology Now

1.15K subscribers